3-V Biosciences' Series C - II Round

3-V Biosciences raised a round of funding on June 23, 2013.

3-V Biosciences is discovering and developing therapeutics that modulate key pathways in oncology and infectious diseases. In oncology, the company's lead candidate is a fatty acid synthase (FASN) inh…

Articles about 3-V Biosciences' Series C - II Round: